RAVELLI, Cosetta
 Distribuzione geografica
Continente #
NA - Nord America 3.578
EU - Europa 2.952
AS - Asia 2.139
SA - Sud America 375
AF - Africa 47
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.109
Nazione #
US - Stati Uniti d'America 3.500
PL - Polonia 1.219
SG - Singapore 698
CN - Cina 685
IT - Italia 555
BR - Brasile 313
UA - Ucraina 268
HK - Hong Kong 266
DE - Germania 241
VN - Vietnam 151
FI - Finlandia 143
GB - Regno Unito 134
IN - India 77
TR - Turchia 73
RU - Federazione Russa 72
IE - Irlanda 62
FR - Francia 56
CA - Canada 45
ID - Indonesia 36
BE - Belgio 34
ES - Italia 33
BD - Bangladesh 32
AR - Argentina 31
NL - Olanda 31
SE - Svezia 27
ZA - Sudafrica 26
JP - Giappone 24
CZ - Repubblica Ceca 23
MX - Messico 18
AT - Austria 15
EC - Ecuador 13
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
AU - Australia 10
IQ - Iraq 10
KR - Corea 7
MY - Malesia 7
PH - Filippine 7
CH - Svizzera 6
EE - Estonia 6
EG - Egitto 6
GR - Grecia 6
KE - Kenya 6
NZ - Nuova Zelanda 6
CO - Colombia 5
IR - Iran 5
KZ - Kazakistan 5
UZ - Uzbekistan 5
VE - Venezuela 5
AL - Albania 4
JM - Giamaica 4
MA - Marocco 4
OM - Oman 4
TH - Thailandia 4
DO - Repubblica Dominicana 3
IL - Israele 3
KG - Kirghizistan 3
PA - Panama 3
RO - Romania 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
MD - Moldavia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
RS - Serbia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 9.109
Città #
Warsaw 1.214
Ashburn 378
Singapore 329
Fairfield 310
Hong Kong 264
Brescia 257
Jacksonville 211
Woodbridge 192
Ann Arbor 190
Chandler 180
Beijing 155
Seattle 135
Houston 123
Wilmington 123
Princeton 114
Cambridge 111
Dearborn 100
New York 100
Los Angeles 97
Dallas 80
Munich 72
Helsinki 70
Milan 68
Dong Ket 63
Nanjing 63
Istanbul 60
The Dalles 60
Dublin 58
Shanghai 38
Buffalo 36
Ho Chi Minh City 36
Turku 35
Jakarta 33
San Francisco 32
Brussels 31
Shenyang 31
São Paulo 30
London 27
Changsha 26
Nanchang 26
Moscow 25
Chicago 24
Des Moines 23
Jinan 23
Madrid 22
San Diego 22
Santa Clara 22
Hanoi 21
Hebei 19
Phoenix 19
Guangzhou 18
Brooklyn 16
Denver 16
Johannesburg 16
Rome 16
Tokyo 16
Atlanta 15
Lappeenranta 15
Olomouc 14
Redondo Beach 14
Toronto 14
Amsterdam 13
Boardman 13
Montreal 13
Nuremberg 13
Stockholm 13
Tianjin 13
Haikou 12
Orem 11
Augusta 10
Chennai 10
Fara Gera d'Adda 10
Frankfurt am Main 10
Hangzhou 10
Zhengzhou 10
Boston 9
Brasília 9
Kunming 9
Washington 9
Charlotte 8
Dhaka 8
Hefei 8
Jiaxing 8
Mexico City 8
Poplar 8
Romola 8
Belo Horizonte 7
Coimbatore 7
Naples 7
Padua 7
San Mateo 7
Brno 6
Curitiba 6
Kilburn 6
Nairobi 6
Padova 6
Paris 6
Pune 6
Redwood City 6
Rio de Janeiro 6
Totale 6.290
Nome #
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 293
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 274
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 273
Claudin3 is localized outside the tight junctions in human carcinomas 272
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 265
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 259
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 258
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 251
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 251
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 210
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 205
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 193
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 181
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 180
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 173
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 172
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 161
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 161
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 157
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 154
Insights on the receptor dynamics during the spreading of endothelial cells 142
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 133
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 133
Vascular disrupting activity of combretastatin analogues 130
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 126
Simulation of VEGF receptor recruitment on ECs membrane 126
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 124
Role of VEGFs in metabolic disorders 124
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 124
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 120
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 118
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 118
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 115
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 108
Role of VEGFR2 co-receptors in the modulation of the pro-angiogenic activity of gremlin. 107
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 105
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 102
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 99
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 98
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 96
Modeling cell motility and receptor dynamics 96
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 95
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 95
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 95
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 95
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 93
VEGFR2 recruitment and activation by substratum-immobilized gremlin 92
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 91
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 91
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 91
VEGFR2 RECRUITMENT AND ACTIVATION BY SUBSTRATE-IMMOBILIZED DRM/GREMLIN 90
Molecular insight on the altered membrane trafficking of TrkA kinase dead mutants 87
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 85
VEGFR2 recruitment and activation by substrate-immobilized VEGF 84
Role of gremlin-1 in the pathophysiology of the adipose tissues 82
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 82
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 80
Mechanobiology of the relocation of proteins in advecting cells: in vitro experiments, multi-physics modeling, and simulations 74
Alternative method to visualize receptor dynamics in cell membranes 74
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 69
The contribution of obesogenic behavior on global warming 69
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 69
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 67
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 66
Deficiency of AP1 Complex Ap1g1 in Zebrafish Model Led to Perturbation of Neurodevelopment, Female and Male Fertility; New Insight to Understand Adaptinopathies 66
The D647N mutation of FGFR1 induces ligand-independent receptor activation 63
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 61
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 61
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 59
FGF-trapping hampers cancer stem-like cells in uveal melanoma 58
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease 50
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 49
Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts 45
The impact of adipokines on vascular networks in adipose tissue 35
Two-Photon Microscopy for the Investigation of Morphological and Quantitative Changes in Skin Chrono- and Photo-Aging 24
A Glucosylated BODIPY Uses the GLUT Channel to Target Cancer Cells in In Vitro and In Vivo Models 5
Totale 9.279
Categoria #
all - tutte 39.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021685 0 0 0 0 0 105 56 110 119 95 107 93
2021/2022531 30 72 9 10 23 42 33 38 41 77 35 121
2022/2023555 82 45 27 29 50 111 13 58 76 9 23 32
2023/2024769 44 33 70 65 56 104 28 63 127 47 19 113
2024/20251.740 46 13 30 266 172 118 153 85 210 112 322 213
2025/20261.833 338 364 241 484 376 30 0 0 0 0 0 0
Totale 9.279